MENU
ALVO
AS OF
Feb 4, 03:40 PM (EDT)
Price
$5.16
Change
-$0.05 (-0.96%)
Capitalization
1.63B
42 days until earnings call
Intraday BUY SELL Signals
+Compare
ALVO
Stock ticker: NASDAQ
AS OF
Feb 4, 03:40 PM (EDT)
Price
$5.16
Change
-$0.05 (-0.96%)
Capitalization
1.63B

ALVO Alvotech Forecast, Technical & Fundamental Analysis

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

ALVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ALVO with price predictions
Feb 03, 2026

ALVO in upward trend: 10-day moving average crossed above 50-day moving average on January 28, 2026

The 10-day moving average for ALVO crossed bullishly above the 50-day moving average on January 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 20, 2026. You may want to consider a long position or call options on ALVO as a result. In of 110 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALVO just turned positive on January 12, 2026. Looking at past instances where ALVO's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

ALVO moved above its 50-day moving average on January 22, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALVO advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where ALVO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALVO entered a downward trend on January 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (29.792). P/E Ratio (22.696) is within average values for comparable stocks, (74.095). ALVO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.035). ALVO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (2.646) is also within normal values, averaging (116.680).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ALVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ALVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALVO is expected to report earnings to fall 117.72% to -8 cents per share on March 18

Alvotech ALVO Stock Earnings Reports
Q4'25
Est.
$-0.08
Q3'25
Beat
by $0.50
Q2'25
Beat
by $0.50
Q1'25
Beat
by $0.32
Q4'24
Missed
by $0.15
The last earnings report on November 12 showed earnings per share of 46 cents, beating the estimate of -2 cents. With 58.36K shares outstanding, the current market capitalization sits at 1.63B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREQX6.360.04
+0.63%
PACE Global Real Estate Securities P
DRRIX17.430.10
+0.58%
BNY Mellon Global Real Return - I
ABSIX21.280.05
+0.24%
AB Discovery Value I
JFDRX13.75-0.05
-0.36%
JHancock Financial Industries R6
JMGFX50.81-0.51
-0.99%
JPMorgan Mid Cap Growth R5

ALVO and Stocks

Correlation & Price change

A.I.dvisor tells us that ALVO and PAHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and PAHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-2.07%
PAHC - ALVO
26%
Poorly correlated
-1.43%
EBS - ALVO
24%
Poorly correlated
-1.45%
CRON - ALVO
23%
Poorly correlated
+2.39%
VTRS - ALVO
22%
Poorly correlated
N/A
ACB - ALVO
22%
Poorly correlated
+3.57%
More

Groups containing ALVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-2.07%
Pharmaceuticals: Generic
industry (214 stocks)
8%
Poorly correlated
-0.59%